Cardiovascular and Metabolic Disorders

Featured Article

Expert Roundtable: AHA Update on Dietary Fat Intake and CVD Risk

Expert Roundtable: AHA Update on Dietary Fat Intake and CVD Risk

The AHA now recommends replacing both saturated and trans fats with unsaturated fats from vegetable oils, nuts, seeds, and oily fish.

Latest

High-Sensitivity CRP and LDL-C Predictive of Subsequent MACE in T2D

High-Sensitivity CRP and LDL-C Predictive of Subsequent MACE in T2D

Levels of high sensitivity C-reactive protein may help risk stratify those patients with T2D and recent acute coronary syndrome at further risk of recurrent cardiovascular events.

High Grip Strength Associated With Lower Risk for Diabetes-Related AEs

High Grip Strength Associated With Lower Risk for Diabetes-Related AEs

Grip strength has clinical utility in identifying people with diabetes at risk for poor health outcomes.

Statin Use for CVD Prevention Increases Diabetes Risk in Overweight Patients

Statin Use for CVD Prevention Increases Diabetes Risk in Overweight Patients

The association between statin use and diabetes risk in a cohort of overweight and obese patients was examined.

FDA Approves Drug for Mucopolysaccharidosis Type VII

FDA Approves Drug for Mucopolysaccharidosis Type VII

Mepsevii replaces beta-glucuronidase, the deficiency of which causes an abnormal buildup of toxic materials in the body's cells.

Postpartum Hypertension in Preeclampsia: Do Puerperal NSAIDs Effect Risk?

Postpartum Hypertension in Preeclampsia: Do Puerperal NSAIDs Effect Risk?

Investigators encourage further research on the use of NSAIDs in women with preeclampsia who develop postpartum hypertension.

Improving Vascular Function in Pediatric T1D With Metformin

Improving Vascular Function in Pediatric T1D With Metformin

Study aimed to determine the effect of metformin on vascular health in children with T1D and above average weight.

Acarbose Reduces Diabetes Risk in Coronary Heart Disease

Acarbose Reduces Diabetes Risk in Coronary Heart Disease

Acarbose, an α-glucosidase inhibitor, decreased the incidence of diabetes in a population with impaired glucose tolerance who were at low risk of cardiovascular events.

Improving NSTEMI Outcomes in T2D With NOCS: Efficacy of Incretin

Improving NSTEMI Outcomes in T2D With NOCS: Efficacy of Incretin

People with type 2 diabetes and NOCS-NSTEMI who used incretin had a better prognosis than non-incretin users.

Severe Hypoglycemia Associated With Increased Mortality Risk in T2D

Severe Hypoglycemia Associated With Increased Mortality Risk in T2D

A study confirms whether severe hypoglycemia increases risk for all-cause mortality in patients with type 2 diabetes.

Glucose Patterns and the Future Development of Diabetes

Glucose Patterns and the Future Development of Diabetes

Study revealed heterogeneity in plasma glucose response to oral glucose intake beyond the established glucose criteria based on fasting plasma glucose and 2 h post-load plasma glucose levels.

Sign Up for Free e-Newsletters

CME Focus